Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Central Nervous System Neoplasms × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Breast Carcinoma In Situ 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1

Interventions

Temozolomide 28 Radiotherapy 20 Bevacizumab 9 Carboplatin 8 Radiation 6 Filgrastim 6 Etoposide 6 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Cyclophosphamide 5 etoposide phosphate 4 Vincristine 4 Ifosfamide 4 Granulocyte Colony-Stimulating Factor 4 Everolimus 4 X-Rays 3 Thalidomide 3 Specimen Handling 3 Phantoms, Imaging 3 Lomustine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 Celecoxib 3 vitespin 2 poly ICLC 2 larotrectinib 2 Thiotepa 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡